Systematic Reviews/Meta-Analyses: Abstract Deadline: March 27, 2023, 11:59 p.m. (PST)
Abstracts must describe a systematic review adhering to the guidelines and definitions established by Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA for Abstracts statement) and include the 12-items published in the PRISMA for
Abstracts checklist (http://www.prisma-statement.org/Extensions/Abstracts).
Abstracts must be structured with the PRISMA for Abstracts format: Background, methods, results, discussion, and other
Abstracts will be evaluated based on merits of the 12 PRISMA for Abstracts checklist items: Title, objectives, eligibility criteria, information sources, risk of bias,
included studies, synthesis of results, description of the effect, strengths and limitations of evidence, interpretation, funding, and registration.
Scoping Reviews: Abstract Deadline: March 27, 2023, 11:59 p.m. (PST)
Abstracts must describe a scoping review adhering to the guidelines and definitions established by Preferred Reporting Items for Scoping Reviews (PRISMA for Scoping Reviews) and include the 10-items described in the ACCP-adapted PRISMA for Abstracts checklist (ACCP-adapted PRISMA for Scoping Review Abstracts checklist).
Abstracts must be structured with the PRISMA for Abstracts format: Background, methods, results, discussion, and other
Abstracts will be evaluated based on merits of the 10 ACCP-adapted PRISMA for Scoping Review Abstracts checklist items: Title, objectives, eligibility criteria, information sources, charting methods, included studies, synthesis of results, limitations, conclusions, and funding. Note: the Evaluation Criteria link above pertains only to Systematic Reviews.
Abstracts presented elsewhere, but important to clinical pharmacy, are encouraged as "Encore" submissions (see Encore Presentation details below).